◆ Market Data --:--
Commodities
Loading...
🌐 Global Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Voyageur Pharmaceuticals Ltd. — SEDAR+ Filings

Open SEDAR+
All Quarterly Reports 20 MD&A 19 News Releases 100 Material Changes 32 Governance 12 Certifications 43 Other 49
DocumentTypeFiling DatePeriodStatus
Notice of meeting - English.pdf Other 2025-05-15 -- PDF
Other.pdf Other 2025-05-15 -- PDF
Report of exempt distribution (45-106F1).pdf Other 2024-12-27 -- PDF
Report of exempt distribution (45-106F1).pdf Other 2024-12-13 -- PDF
Statement of executive compensation (form 51-102F6V) - English.pdf Other 2024-06-24 -- PDF
Notice of meeting - English.pdf Other 2023-06-06 -- PDF
Notice of the meeting and record date (amended) - English.pdf Other 2023-05-18 -- PDF
Notice of the meeting and record date - English.pdf Other 2023-04-14 -- PDF
Notice of meeting - English.pdf Other 2022-09-06 -- PDF
Notice of the meeting and record date (amended) - English.pdf Other 2022-08-02 -- PDF
Notice of the meeting and record date - English.pdf Other 2022-07-29 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2022-06-27 -- PDF
Letter from successor auditor.pdf Other 2021-11-30 -- PDF
Notice.pdf Other 2021-11-30 -- PDF
Letter from former auditor.pdf Other 2021-11-30 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2021-06-07 -- PDF
Notice of meeting - English.pdf Other 2021-06-01 -- PDF
Notice of the meeting and record date (amended) - English.pdf Other 2021-05-17 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2021-05-14 -- PDF
Technical report (NI 43-101) - English.pdf Other 2020-12-18 -- PDF
Consent of qualified person (NI 43-101) - English.pdf Other 2020-12-18 -- PDF
Consent of qualified person (NI 43-101) - English.pdf Other 2020-12-18 -- PDF
Consent of qualified person (NI 43-101) - English.pdf Other 2020-10-30 -- PDF
Amended & restated technical report (NI 43-101) - English.pdf Other 2020-10-30 -- PDF
Statement of executive compensation (form 51-102F6V) - English.pdf Other 2020-10-09 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2019-12-09 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2019-11-12 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2019-11-12 -- PDF
Certificate re dissemination to shareholders.pdf Other 2019-10-11 -- PDF
Notice of meeting - English.pdf Other 2019-10-10 -- PDF
Other.PDF Other 2019-10-10 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2019-09-26 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2019-09-20 -- PDF
Notice of the meeting and record date - English.pdf Other 2019-09-05 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2018-11-07 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2018-09-28 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2018-09-06 -- PDF
Consent of qualified person (NI 43-101) - English.pdf Other 2018-07-24 -- PDF
Consent of qualified person (NI 43-101) - English.pdf Other 2018-07-24 -- PDF
Technical report (NI 43-101) - English.pdf Other 2018-07-24 -- PDF
Notice Form 45-102F1.pdf Other 2018-07-05 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2018-06-15 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2017-12-08 -- PDF
Letter from successor auditor.PDF Other 2017-09-19 -- PDF
Letter from former auditor.PDF Other 2017-09-19 -- PDF
Notice.PDF Other 2017-09-19 -- PDF
Report of exempt distribution excluding schedule 1 of Form 5.pdf Other 2017-08-08 -- PDF
Other.pdf Other 2017-06-08 -- PDF
Notice of meeting - English.pdf Other 2017-06-08 -- PDF
NEWS
Loading news...
TRENDING
Loading...